MedTrace Logo

Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

NCT00136058 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2011-12-16

No results posted yet for this study

Summary

The objective of this study is to determine if an intervention with a fracture manager to arrange bone densitometry after a hip fracture is more effective in diagnosing and treating osteoporosis when compared to "usual care". "Usual care" consists of no intervention to arrange bone mineral density (BMD) testing or therapy other than what normally occurs in the community. The investigators postulate that a fracture manager will be more effective in getting BMD done and in starting appropriate therapy.

Conditions

Interventions

PROCEDURE

bone densitometry (DEXA)

DRUG

alendronate or risedronate

Sponsors & Collaborators

  • Alberta Heritage Foundation for Medical Research

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Donald W Morrish, MD, PhD · University of Alberta

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Completion
2006-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00136058 on ClinicalTrials.gov